Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation
Lamin B2 调节心肌细胞终末分化中的核重塑
基本信息
- 批准号:10372035
- 负责人:
- 金额:$ 38.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAdolescentAdultApoptosisBirthCaliberCardiac MyocytesCell CycleCell DeathCell NucleusCellsCessation of lifeChildhoodChromatinChromatin StructureChronicCommunicationCytoplasmDevelopmentDiseaseEventGene ExpressionGene Expression ProfilingGene SilencingGene TransferGenesGenetic TranscriptionGrowthHealthHeartHeart DiseasesHeart InjuriesHeart failureHumanInjuryInterdisciplinary StudyIntermediate FilamentsIschemiaLeadMammalsMicroscopyMitosisModelingMolecularMorbidity - disease rateMusMyocardialNatural regenerationNeonatalNuclearNuclear ImportNuclear LaminaNuclear PoreOutcomePatientsPloidiesPolyploidyPredispositionProgressive DiseasePublic HealthRegenerative MedicineRegenerative capacityReperfusion TherapyResearchResistanceResolutionRoleSignal TransductionSignaling MoleculeSpecificityTechniquesTestingViralWithdrawalWorkcardiac regenerationcardiogenesiscdc Genesgain of functionheart functionin vivoinnovationknockout genelamin B2loss of functionmortalitymouse modelmyocardial injuryneonatal micenew therapeutic targetnovel therapeuticsnucleocytoplasmic transportsingle-cell RNA sequencingtranscriptome sequencing
项目摘要
ABSTRACT
Heart disease is the leading cause of morbidity and mortality worldwide. Different types of heart injury lead to
the development of heart failure, a chronically progressive disease. Heart failure is characterized by increased
cardiomyocyte death and insufficient regeneration of new ones. As such, increasing cardiomyocyte
regeneration and decreasing death represent targets for new therapies. This application is for developing a
transformative paradigm connecting these important cellular mechanisms with nuclear remodeling in
cardiomyocyte differentiation.
Our new results show that when cardiomyocytes differentiate they decrease the number of nuclear
pores (NP). NP are large channels of > 100 nm outer diameter for communication between the nucleus and
the cytoplasm. NP, along with the nuclear lamina (NL), function in regulating the nuclear transport of signaling
molecules and chromatin organization. Although heart failure alters nuclear transport, the structural and
functional changes of NL and NP changes during terminal differentiation are unknown. To determine the
molecular mechanisms directing the decrease of NP, we have used single-cell transcriptional profiling, which
identified a decrease in expression of lamin B2 (Lmnb2), an intermediate filament and component of the NL,
during cardiomyocyte differentiation. Our new results show that Lmnb2 gene knockout in cardiomyocytes
blocks M-phase, that is, nuclei do not divide, and instead become polyploid. In addition, the M-phase block
decreases NP incorporation. As a result, although the DNA contents of nuclei (ploidy) increases, the number of
NP decreases by 50%. The lower NP number identifies a central event in nuclear remodeling, as it indicates
not only altered nuclear transport, but also altered chromatin structure. Together, this could explain the
decreased ability of terminally differentiated cardiomyocytes to activate cell cycle genes and their increased
susceptibility to cell death.
This proposal aims to develop a new mechanistic paradigm of nuclear remodeling in cardiomyocyte
differentiation, which is synergistic with recent advances in characterizing chromatin changes. We will test the
central hypothesis that decreased Lmnb2 gene expression is a central mechanism of nuclear
remodeling in cardiomyocyte differentiation. We have assembled an interdisciplinary research team and
prepared innovative techniques (super-resolution microscopy, single-cell RNAseq, ATACseq) that, combined
with cardiomyocyte-specific Lmnb2flox inactivation and viral expression of Lmnb2, will enable us to determine its
role in nuclear remodeling in cardiomyocyte differentiation.
The anticipated results will enable future research toward understanding and targeting nuclear
remodeling in myocardial development, regeneration, and disease. This will be broadly significant for patients
with congenital and acquired heart diseases.
抽象的
心脏病是全球发病率和死亡率的主要原因。不同类型的心脏损伤导致
心力衰竭的发展,一种长期进行性疾病。心力衰竭的特征是增加
心肌细胞死亡和新的再生不足。因此,增加心肌细胞
再生和死亡减少代表新疗法的靶标。该应用程序用于开发一个
将这些重要的细胞机制与核重塑连接起来的变化范式
心肌细胞分化。
我们的新结果表明,当心肌细胞区分时,它们会减少核的数量
孔(NP)。 NP是> 100 nm外径的大通道,用于在细胞核之间通信
细胞质。 NP与核层(NL)一起在调节信号传导的核转运方面发挥作用
分子和染色质组织。尽管心力衰竭改变了核运输,但结构和
NL和NP在终端分化过程中的功能变化尚不清楚。确定
指导NP减少的分子机制,我们使用了单细胞转录分析,
鉴定出lamin B2(LMNB2)的表达降低,NL的中间丝和成分,
在心肌细胞分化过程中。我们的新结果表明,心肌细胞中的LMNB2基因敲除
块M期,即核不分裂,而是变成多倍体。另外,M相块
减少NP掺入。结果,尽管核的DNA含量(倍性)增加,但数量
NP降低50%。 NP较低的数字标识了核重塑的中心事件,因为它表明
不仅改变了核转运,还改变了染色质结构。一起,这可以解释
终末分化的心肌细胞激活细胞周期基因的能力降低了,它们的增加
对细胞死亡的敏感性。
该建议旨在开发心肌细胞中核重塑的新机械范式
分化,这是表征染色质变化的最新进展。我们将测试
降低LMNB2基因表达是核的中心假设
心肌细胞分化中的重塑。我们组建了一个跨学科研究团队,
准备的创新技术(超分辨率显微镜,单细胞RNASEQ,atacseq),合并
随着心肌细胞特异性LMNB2Flox灭活和LMNB2的病毒表达,将使我们确定其
在心肌细胞分化中核重塑中的作用。
预期的结果将使未来的研究能够理解和靶向核
重塑心肌发育,再生和疾病。这对于患者来说是显着意义的
与先天性和心脏病有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernhard Kuhn其他文献
Bernhard Kuhn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernhard Kuhn', 18)}}的其他基金
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10427418 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10630817 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10840490 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10295053 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation
Lamin B2 调节心肌细胞终末分化中的核重塑
- 批准号:
10579284 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
- 批准号:
10413070 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
- 批准号:
10625836 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
- 批准号:
10191031 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Myofibril disassembly during neonatal heart muscle cell proliferation
新生儿心肌细胞增殖过程中的肌原纤维解体
- 批准号:
8386967 - 财政年份:2010
- 资助金额:
$ 38.22万 - 项目类别:
Myofibril disassembly during neonatal heart muscle cell proliferation
新生儿心肌细胞增殖过程中的肌原纤维解体
- 批准号:
8780671 - 财政年份:2010
- 资助金额:
$ 38.22万 - 项目类别:
相似国自然基金
青少年肌阵挛性癫痫发作控制与复发的脑网络系统动力稳定性大时间尺度演化机制研究
- 批准号:82301640
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
- 批准号:82373595
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
- 批准号:32300894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
- 批准号:82371557
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
相似海外基金
At the right time and place – identifying epigenetic and molecular determinants of a developmental learning window
在正确的时间和地点 – 识别发育学习窗口的表观遗传和分子决定因素
- 批准号:
10575177 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Population-level and mechanistic dissection of 17q21 structural variant association with psychiatric traits
17q21 结构变异与精神特征关联的群体水平和机制剖析
- 批准号:
10732393 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Microglial contribution to Down Syndrome Neuropathology
小胶质细胞对唐氏综合症神经病理学的贡献
- 批准号:
10566660 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别: